UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 83 filers reported holding UROGEN PHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -8.3% | 1,282 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -45.5% | 1,282 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 1,282 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -20.0% | 1,282 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +8.7% | 1,282 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | -8.0% | 1,282 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -24.2% | 1,282 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +43.5% | 1,282 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -46.5% | 1,282 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | -25.9% | 1,282 | -47.0% | 0.00% | – |
| Q3 2019 | $58,000 | -33.3% | 2,421 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $87,000 | -2.2% | 2,421 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | +81.6% | 2,421 | +112.6% | 0.00% | – |
| Q4 2018 | $49,000 | -9.3% | 1,139 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | -5.3% | 1,139 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $57,000 | – | 1,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |